-
公开(公告)号:US11965152B2
公开(公告)日:2024-04-23
申请号:US16783275
申请日:2020-02-06
申请人: Lonza Ltd.
发明人: Thaddaeus Webster , Carrie Mason , Tristan Wilkins
IPC分类号: C12M1/34 , B01F23/45 , B01J19/00 , B01F101/22
CPC分类号: C12M41/26 , B01F23/45 , B01J19/0086 , C12M1/3407 , C12M1/3453 , C12M41/12 , B01F2101/22 , Y10T436/108331
摘要: The monitoring and control of bioprocesses is provided. More particularly, the present disclosure is directed to formulating buffer products from multiple buffer solutions for feeding the different operations occurring within a bioprocess line. As the buffer product is being formulated, the buffer product is tested for conductivity, refractive index, and optionally pH. The conductivity measurements are used in conjunction with refractive index measurements to ensure that the buffer product not only has the correct concentration of ions but also has the correct concentration of components. A controller can be used to make automatic adjustments to the buffer product should any of the measured parameters fall outside a preset range.
-
公开(公告)号:US11898137B2
公开(公告)日:2024-02-13
申请号:US16876498
申请日:2020-05-18
申请人: LONZA LTD
发明人: Tristan Wilkins
摘要: A method for delivering a processing solution includes providing a concentrated processing solution in a bioprocess container, the concentrated processing solution being produced at a first site. The method also includes combining the concentrated processing solution with a biopolymer containing solution produced in a bioreactor at a second site different from the first site. In some embodiments, the processing solution is a buffer for processing products of cells cultured in a bioreactor. A system and a pharmaceutical production facility for carrying out the method is also provided.
-
公开(公告)号:US11859403B2
公开(公告)日:2024-01-02
申请号:US17826856
申请日:2022-05-27
申请人: LONZA LTD
发明人: Leander Biffiger , Sandra Carbonneau , Andre Collioud , Jonathan Fortin , Dominique Imboden , Torsten Schmidt , Stefan Stoffel , Diego Studer , Christoph Vogel , Stefan Widmer , Tristan Wilkins , Lesley Wood , Alexander Zahiri
摘要: A campus for fabricating at least one pharmaceutical product has one or more customizable facilities each configured to manufacture the at least one pharmaceutical product, a media/buffer plant, and a utility building connected by a utility line to the media/buffer plant and/or the one or more customizable facilities to provide at least one first utility to the media/buffer plant and/or the one or more customizable facilities via the utility line.
-
公开(公告)号:US20170321443A1
公开(公告)日:2017-11-09
申请号:US15659390
申请日:2017-07-25
申请人: LONZA LTD
发明人: Leander Biffiger , Sandra Carbonneau , Andre Collioud , Jonathan Fortin , Dominik Imbolden , Torsten Schmidt , Stefan Stoffel , Diego Studer , Christoph Vogel , Stefan Widmer , Tristan Wilkins , Lesley Wood , Alexander Zahiri
摘要: A campus for fabricating at least one pharmaceutical product has one or more customizable facilities each configured to manufacture the at least one pharmaceutical product, a media/buffer plant, and a utility building connected by a utility line to the media/buffer plant and/or the one or more customizable facilities to provide at least one first utility to the media/buffer plant and/or the one or more customizable facilities via the utility line.
-
公开(公告)号:US20240360398A1
公开(公告)日:2024-10-31
申请号:US18769485
申请日:2024-07-11
申请人: Lonza Ltd
发明人: John Gunst , Jonathan Fortin , Tristan Wilkins
摘要: The present disclosure is directed to the organic growth and phasing design for a system for the industrial growth of biologics. A system may include a number of subsystems, such as a buffer distribution subsystem, a media preparation subsystem, a bioreactor subsystem, a harvest subsystem, and/or a purification subsystem. The subsystems may be highly interconnected for flexible process flow design. Additionally, the subsystems may be constructed with a total output capacity with a total number of equipment stations and operated at a lower output capacity with fewer than the total equipment stations to maintain headroom for growth in phases.
-
公开(公告)号:US12071607B2
公开(公告)日:2024-08-27
申请号:US16408819
申请日:2019-05-10
申请人: Lonza Ltd.
发明人: John Gunst , Jonathan Fortin , Tristan Wilkins
摘要: The present disclosure is directed to the organic growth and phasing design for a system for the industrial growth of biologics. A system may include a number of subsystems, such as a buffer distribution subsystem, a media preparation subsystem, a bioreactor subsystem, a harvest subsystem, and/or a purification subsystem. The subsystems may be highly interconnected for flexible process flow design. Additionally, the subsystems may be constructed with a total output capacity with a total number of equipment stations and operated at a lower output capacity with fewer than the total equipment stations to maintain headroom for growth in phases.
-
公开(公告)号:US10669518B2
公开(公告)日:2020-06-02
申请号:US15667387
申请日:2017-08-02
申请人: LONZA LTD
发明人: Tristan Wilkins
摘要: A method for delivering a processing solution includes providing a concentrated processing solution in a bioprocess container, the concentrated processing solution being produced at a first site. The method also includes combining the concentrated processing solution with a biopolymer containing solution produced in a bioreactor at a second site different from the first site. In some embodiments, the processing solution is a buffer for processing products of cells cultured in a bioreactor. A system and a pharmaceutical production facility for carrying out the method is also provided.
-
公开(公告)号:US11377865B2
公开(公告)日:2022-07-05
申请号:US16883505
申请日:2020-05-26
申请人: LONZA LTD
发明人: Leander Biffiger , Sandra Carbonneau , Andre Collioud , Jonathan Fortin , Dominik Imbolden , Torsten Schmidt , Stefan Stoffel , Diego Studer , Christoph Vogel , Stefan Widmer , Tristan Wilkins , Lesley Wood , Alexander Zahiri
摘要: A campus for fabricating at least one pharmaceutical product has one or more customizable facilities each configured to manufacture the at least one pharmaceutical product, a media/buffer plant, and a utility building connected by a utility line to the media/buffer plant and/or the one or more customizable facilities to provide at least one first utility to the media/buffer plant and/or the one or more customizable facilities via the utility line.
-
公开(公告)号:US20200255792A1
公开(公告)日:2020-08-13
申请号:US16783275
申请日:2020-02-06
申请人: Lonza Ltd.
发明人: Thaddaeus Webster , Carrie Mason , Tristan Wilkins
摘要: The monitoring and control of bioprocesses is provided. More particularly, the present disclosure is directed to formulating buffer products from multiple buffer solutions for feeding the different operations occurring within a bioprocess line. As the buffer product is being formulated, the buffer product is tested for conductivity, refractive index, and optionally pH. The conductivity measurements are used in conjunction with refractive index measurements to ensure that the buffer product not only has the correct concentration of ions but also has the correct concentration of components. A controller can be used to make automatic adjustments to the buffer product should any of the measured parameters fall outside a preset range.
-
公开(公告)号:US10689873B2
公开(公告)日:2020-06-23
申请号:US15659390
申请日:2017-07-25
申请人: LONZA LTD
发明人: Leander Biffiger , Sandra Carbonneau , Andre Collioud , Jonathan Fortin , Dominik Imbolden , Torsten Schmidt , Stefan Stoffel , Diego Studer , Christoph Vogel , Stefan Widmer , Tristan Wilkins , Lesley Wood , Alexander Zahiri
摘要: A campus for fabricating at least one pharmaceutical product has one or more customizable facilities each configured to manufacture the at least one pharmaceutical product, a media/buffer plant, and a utility building connected by a utility line to the media/buffer plant and/or the one or more customizable facilities to provide at least one first utility to the media/buffer plant and/or the one or more customizable facilities via the utility line.
-
-
-
-
-
-
-
-
-